J Korean Diabetes > Volume 17(3); 2016 > Article
The Journal of Korean Diabetes 2016;17(3):164-167.
DOI: https://doi.org/10.4093/jkd.2016.17.3.164    Published online October 13, 2016.
투석 환자의 혈당관리
Glycemic Management of Patients Undergoing Dialysis.
Mi Kyung Kim
Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea. mdkmk@dsmc.or.kr
Diabetes mellitus is the leading cause of end-stage renal disease in Korea. The management of glycemic control in patients undergoing dialysis is challenging due to the complexity of the treatment and the lack of convincing data supporting the benefits of tight glycemic control. When kidney function decreased, glucose homeostasis changed. Increased insulin resistance due to uremia and decreased insulin secretion resulted in hyperglycemia, and decreased counter-regulatory hormone and renal gluconeogenesis led to hypoglycemia. Moreover, glycosylated hemoglobin is affected by various factors in patients undergoing dialysis, so it is difficult to monitor for glycemic control. Decreased kidney function changes the pharmacokinetics of drugs. Some oral hypoglycemic agents are used for patients undergoing dialysis, but the main treatment for glycemic control is insulin. Considering these factors, the management of glycemic control for patients undergoing dialysis is delicate and should be individualized based on the patient's risk profile.
Key Words: Dialysis, Glucose

Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2021 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer